News
-
-
-
PRESS RELEASE
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
Heidelberg Pharma AG reports significant progress in the first quarter of 2026 financially and in clinical development, completion of Phase I clinical trial, milestone payments triggered, and extended cash reach -
-
-
PRESS RELEASE
Blue Cap AG successfully concludes fiscal year 2025 and proposes record dividend of EUR 1.60 per share
Blue Cap AG reports successful fiscal year 2025 with record dividend proposal of EUR 1.60 per share and robust financial performance. Forecast for 2026 confirmed amid market challenges -
-
PRESS RELEASE
VIB Vermögen AG: Positive business development continued in the 2025 financial year
VIB Vermögen AG's positive business development continued in the 2025 financial year, achieving all targets with increased FFO and gross rental income. Company diversified portfolio and guidance for 2026 shared -
-